Family

Country	kind	publication No.	Filing Date	Type	Sub-Type

• 15 United States
• 10 France
• 8 Japan
• 7 China
• 5 Korea
• 2 Other

Patent Owner(s)

• PARADIGM SERVICES LIMITED

International Classification(s)

• 1803:TYPE AND TYPE FACES

• 2007 Application Filing Year
• 1803 Class
• 8 Applications Filed
• 8 Patents Issued To-Date
• 100 % Issued To-Date

Inventor(s)

Inventor Name	Address	# of filed Patents	Total Citations
Buck, Spencer	Weston-Super-Mare, GB	11	62
# of filed Patents : 11 Total Citations : 62

Cited Art Landscape

Load Citation

• No Cited Art to Display

Loading Cited Art Landscape...

Patent Citation Ranking

• 1 Citation Count
• 1803 Class

• 0 % this patent is cited more than
• 15 Age

Forward Cite Landscape

Load Citation

• No Forward Cites to Display

Loading Forward Cite Landscape...

Maintenance Fees

Fee	Large entity fee	small entity fee	micro entity fee	due date

Fee	Large entity fee	small entity fee	micro entity fee
Surcharge after expiration - Late payment is unavoidable	$700.00	$350.00	$175.00
Surcharge after expiration - Late payment is unintentional	$1,640.00	$820.00	$410.00

Full Text

US Patent No: 8354396

Drug identification and treatment method

---

Abstract

---

The invention relates to methods to identify compounds that can treat autoimmune conditions and treat specified clinical disorders such as multiple sclerosis, ulcerative colitis or arthritis. Compounds include 17α-ethynylandrost-5-ene-3β,11β,7α,17β-tetrol, 4α-acetoxy-17α-ethynylandrost-5-ene-3β,7β,17β-triol, 17α-ethynylandrost-5-ene-3β,4β,7α,17β-tetrol, 17α-ethynylandrost-5-ene-3α,4β,7α,17β-tetrol and 17α-ethynylandrost-5-ene-3α,4β,17β-triol-7-one.

---

 

---

Description

---

Claims

---

Claims data not available

---

Legal Events

 

• AS2024
• MAFP2024
• AS2021
• AS2021
• MAFP2020
• SULP2016
• FPAY2016
• REMI2016
• AS2015
• AS2014
• I2013
• STCF2012
• AS2012
• AS2012
• AS2010
• P2008
• AS2008
• F2007
• PD2006

Date	Code	Event	Description
Dec 05, 2024	AS	ASSIGNMENT	free format text: RELEASE BY SECURED PARTY;ASSIGNOR:AVENUE VENTURE OPPORTUNITIES FUND, L.P.;REEL/FRAME:069510/0814 Owner name: BIOVIE INC., NEVADA Effective Date: Dec 05, 2024
Jul 15, 2024	MAFP	MAINTENANCE FEE PAYMENT	free format text: PAYMENT OF MAINTENANCE FEE, 12TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2553); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY year of fee payment: 12
Nov 30, 2021	AS	ASSIGNMENT	free format text: SECURITY INTEREST;ASSIGNOR:BIOVIE INC.;REEL/FRAME:058329/0389 Owner name: AVENUE VENTURE OPPORTUNITIES FUND, L.P., NEW YORK Effective Date: Nov 30, 2021
Aug 08, 2021	AS	ASSIGNMENT	free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:NEURMEDIX, INC.;REEL/FRAME:057116/0336 Owner name: NEURMEDIX, LLC, CALIFORNIA Effective Date: Jan 25, 2020 free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:NEURMEDIX, LLC;REEL/FRAME:057116/0362 Owner name: NEURMEDIX, INC., CALIFORNIA Effective Date: Aug 08, 2021 free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:NEURMEDIX, INC.;REEL/FRAME:057116/0451 Owner name: BIOVIE INC., CALIFORNIA Effective Date: Aug 08, 2021
Apr 21, 2020	MAFP	MAINTENANCE FEE PAYMENT	free format text: PAYMENT OF MAINTENANCE FEE, 8TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2552); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY year of fee payment: 8
Sep 15, 2016	SULP	SURCHARGE FOR LATE PAYMENT
Sep 15, 2016	FPAY	FEE PAYMENT	year of fee payment: 4
Aug 26, 2016	REMI	MAINTENANCE FEE REMINDER MAILED
Feb 16, 2015	AS	ASSIGNMENT	free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:RESERVA LLC;REEL/FRAME:035026/0292 Owner name: NEURMEDIX INC., CALIFORNIA Effective Date: Feb 16, 2015
Dec 09, 2014	AS	ASSIGNMENT	free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:HARBOR THERAPEUTICS, INC.;REEL/FRAME:046828/0014 Owner name: RESERVA, LLC, CALIFORNIA Effective Date: Dec 09, 2014
Jan 15, 2013	I	Issuance
Dec 22, 2012	STCF	INFORMATION ON STATUS: PATENT GRANT	free format text: PATENTED CASE
Nov 01, 2012	AS	ASSIGNMENT	free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:HARBOR DIVERSIFIED, INC.;REEL/FRAME:046629/0331 Owner name: HARBOR THERAPEUTICS, INC., CALIFORNIA Effective Date: Nov 01, 2012
Feb 01, 2012	AS	ASSIGNMENT	free format text: CHANGE OF NAME;ASSIGNOR:HARBOR BIOSCIENCES, INC.;REEL/FRAME:029227/0929 Owner name: HARBOR DIVERSIFIED, INC., CALIFORNIA Effective Date: Feb 01, 2012
Feb 09, 2010	AS	ASSIGNMENT	free format text: CHANGE OF NAME;ASSIGNOR:HOLLIS-EDEN PHARMACEUTICALS, INC.;REEL/FRAME:024066/0325 Owner name: HARBOR BIOSCIENCES, INC.,CALIFORNIA Effective Date: Feb 09, 2010 free format text: CHANGE OF NAME;ASSIGNOR:HOLLIS-EDEN PHARMACEUTICALS, INC.;REEL/FRAME:024066/0325 Owner name: HARBOR BIOSCIENCES, INC., CALIFORNIA Effective Date: Feb 09, 2010
Jun 26, 2008	P	Published
Mar 05, 2008	AS	ASSIGNMENT	free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:FRINCKE, JAMES M.;READING, CHRISTOPHER;AUCI, DOMINICK;AND OTHERS;REEL/FRAME:020602/0745;SIGNING DATES FROM 20080226 TO 20080229 Owner name: HOLLIS-EDEN PHARMACEUTICALS, INC., CALIFORNIA free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:FRINCKE, JAMES M.;READING, CHRISTOPHER;AUCI, DOMINICK;AND OTHERS;SIGNING DATES FROM 20080226 TO 20080229;REEL/FRAME:020602/0745 Owner name: HOLLIS-EDEN PHARMACEUTICALS, INC., CALIFORNIA
Nov 17, 2007	F	Filing
Nov 17, 2006	PD	Priority Date